Increased levels of tumor-infiltrating CD8+ T cells are generally associated with favorable prognosis (5–7), whereas M2-like tumor-associated macrophages (TAMs) and T regulatory (Treg) cells have been widely recognized as negative prognostic indicators in cancers (8–10). Here, CD8A is linked to cancer.